| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4594162
Max Phase: Preclinical
Molecular Formula: C21H23NO4
Molecular Weight: 353.42
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: C=CC[C@H]1C[C@]2([C@@H](C)Cc3ccc(OC)c(C#N)c3)OCOC2=CC1=O
Standard InChI: InChI=1S/C21H23NO4/c1-4-5-16-11-21(20(10-18(16)23)25-13-26-21)14(2)8-15-6-7-19(24-3)17(9-15)12-22/h4,6-7,9-10,14,16H,1,5,8,11,13H2,2-3H3/t14-,16-,21+/m0/s1
Standard InChI Key: JWKVIBKLNXCNLK-WDUKFBBWSA-N
Associated Targets(Human)
M14 47487 Activities
NCI-H460 60772 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 353.42 | Molecular Weight (Monoisotopic): 353.1627 | AlogP: 3.54 | #Rotatable Bonds: 6 |
| Polar Surface Area: 68.55 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.85 | CX LogD: 3.85 |
| Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.73 | Np Likeness Score: 1.05 |
References
| 1. Huang Z, Williams RB, Martin SM, Lawrence JA, Norman VL, O'Neil-Johnson M, Harding J, Mangette JE, Liu S, Guzzo PR, Starks CM, Eldridge GR.. (2018) Bifidenone: Structure-Activity Relationship and Advanced Preclinical Candidate., 61 (15): [PMID:29995409] [10.1021/acs.jmedchem.7b01644] |
Source
Source(1):